Other Clinical Trial - Propofolsleep - A Study on Cardiopulmonary &

Status Active, not recruiting

Clinical Trial Summary

While Drug Induced Sleep Endoscopy (DISE) in patients with obstructive sleep apnea syndrome (OSAS) apnea and hypopnea occur. Because of the induced phases of apnea in a controlled setting it is possible to evaluate the related pathophysiology of apnea. We plan to correlate the Patient State Index (PSI) and other physiologic parameters with phases of apnea and hypopnea.

Clinical Trial Description

DISE is a standard method in diagnosis of OSAS and its specific localisation and severity. 20 patients with polysomnographic diagnosed OSAS will be enrolled in this prospective observational study. All patients would get a DISE because of the before mentioned reasons (localisation and severity) although they wouldn't participate in this study. They will get a 24-h-RR (blood pressure)-measurement, a transthoracic echocardiography, a peak-flow-test and routine lab examination including troponin and proBNP before the examination. Furthermore they have to fill out the Epworth Sleepiness Scale questionaire.

Before starting the DISE a standard-monitoring (Electrocardiography, pulse oximetry, non-invasive blood pressure, patient state index, near infrared spectroscopy, transcutaneous CO2 (carbon dioxide), invasive blood pressure) will be established. After applying the monitoring the DISE is started by target controlled infusion (Marsh Model) with a sighted goal-concentration of 3.0 µg/ml Propofol in 5 minutes. While the examination a stabile snoring-phase with apnoea/hypopnoea is needed. In this moment a video-endoscopy is started to quantify the level of obstruction. After DISE the sedation will end and the patients will be transported to the recovery room or postanesthesia care unit (PACU). For specific order of events a video recording of the DISE will be realized. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03224936
Study type	Observational
Source	Charite University, Berlin, Germany
Contact
Status	Active, not recruiting
Phase
Start date	August 22, 2017
Completion date	December 31, 2019

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT03605329` - Evaluation of the Severity of Cardiovascular Autonomic Neuropathy in Type 1 Diabetic Patients With OSAS	N/A
Completed	`NCT04912635` - Evaluation of a Health Dashboard Intervention to Improve Engagement With CPAP Therapy in PAP-Naïve Patients: Project Neo	N/A
Not yet recruiting	`NCT05939934` - Impact of the Mandibular Advancement Device on Sleep Apnea During CPAP Withdrawal	N/A
Enrolling by invitation	`NCT02290236` - Monitored Saturation Post-ICU	N/A
Terminated	`NCT02269774` - Origin of Premature Atrial Beats Induced by Simulated Obstructive Sleep Apnea	N/A
Completed	`NCT02088723` - Testing the Elevation as Sleep Apnea Treatment	N/A
Completed	`NCT02261857` - 3D-Printed CPAP Masks for Children With Obstructive Sleep Apnea	Early Phase 1
Completed	`NCT01181570` - Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea	Phase 4
Completed	`NCT01943708` - Novel Auto-continuous Positive Airway Pressure (CPAP) Validation	Phase 3
Completed	`NCT00273754` - The Effect of Caffeine on Postextubation Adverse Respiratory Events in Children With Obstructive Sleep Apnea (OSA).	Phase 2
Recruiting	`NCT02166879` - Undetected Sleep Apnea in the Postanesthesia Acute Care Unit (PACU)
Recruiting	`NCT04963192` - Integrated Management of Chronic Respiratory Diseases	N/A
Completed	`NCT04846400` - Pilot Study of a Self-Supporting Nasopharyngeal Airway in Hypotonia	N/A
Completed	`NCT05056766` - How Does the Clinical and Paraclinical Efficacy of an Oral Appliance Evolved According to Propulsion: Control With Each mm of Advancement
Recruiting	`NCT04314492` - Intracapsular Tonsillectomy in the Treatment of Obstructive Sleep Apnea in Adults	N/A
Completed	`NCT05175287` - OSA (oRisk of Obstructive Sleep Apnea and Traffic Accidents Among Bus Drivers in Ecuador: is There a Significant Association
Active, not recruiting	`NCT03431038` - Cross-sectional Study of Prevalence Rate of Abdominal Aortic Aneurysm in OSAHS Patients From BTCH	N/A
Enrolling by invitation	`NCT03075787` - Cardiovascular Variability and Heart Rate Response Associated With Obstructive Sleep Apnea	N/A
Completed	`NCT03300037` - HYpopnea and Apnea Detection and Treatment Performance of a New cardiOreSpiratory Holter Monitor	N/A
Recruiting	`NCT06097949` - AcuPebble to Remotely Monitor Patients With OSA on CPAP Therapy

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Propofolsleep - A Study on Cardiopulmonary and Pharyngeal Reactions While Drug Induced Sleep Endoscopy (DISE)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms